Nuwellis (NUWE) Profit After Tax Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.75% |
| Dec 31, 2025 | 4.73% |
| Sep 30, 2025 | 16.10% |
| Jun 30, 2025 | -26.20% |
| Mar 31, 2025 | 7.98% |
| Dec 31, 2024 | 19.89% |
| Sep 30, 2024 | 20.33% |
| Jun 30, 2024 | -11.76% |
| Mar 31, 2024 | 1.74% |
| Dec 31, 2023 | -5.30% |
| Sep 30, 2023 | 4.49% |
| Jun 30, 2023 | -2.99% |
| Mar 31, 2023 | -8.29% |
| Dec 31, 2022 | 23.29% |
| Sep 30, 2022 | -6.33% |
| Jun 30, 2022 | -11.76% |
| Mar 31, 2022 | -36.61% |
| Dec 31, 2021 | -8.34% |
| Sep 30, 2021 | -6.12% |
| Jun 30, 2021 | -2.47% |
| Mar 31, 2021 | -1.76% |
| Dec 31, 2020 | 14.11% |
| Sep 30, 2020 | 8.27% |
| Jun 30, 2020 | 9.21% |
| Mar 31, 2020 | 8.35% |
| Dec 31, 2019 | 7.81% |
| Sep 30, 2019 | 5.96% |
| Jun 30, 2019 | 7.04% |
| Mar 31, 2019 | 5.68% |
| Dec 31, 2018 | 9.74% |
| Sep 30, 2018 | 6.81% |
| Jun 30, 2018 | 0.19% |
| Mar 31, 2018 | 0.21% |
| Dec 31, 2017 | -11.69% |
| Sep 30, 2017 | 2.89% |
| Jun 30, 2017 | 1.28% |
| Mar 31, 2017 | 25.45% |
| Dec 31, 2016 | -58.39% |
| Sep 30, 2016 | 3.46% |
| Jun 30, 2016 | -3.82% |
| Mar 31, 2016 | -11.18% |